(3beta,5beta)-3-[(trans-2,5-Dimethyl-4-{[2-(trifluoromethyl)phenyl]-sulfonyl}piperazin-1-yl)methyl]-3-hydroxyandrostan-17-one

ID: ALA4076831

PubChem CID: 137650722

Max Phase: Preclinical

Molecular Formula: C33H47F3N2O4S

Molecular Weight: 624.81

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  C[C@@H]1CN(S(=O)(=O)c2ccccc2C(F)(F)F)[C@@H](C)CN1C[C@]1(O)CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@@]2(C)C(=O)CC[C@@H]32)C1

Standard InChI:  InChI=1S/C33H47F3N2O4S/c1-21-19-38(43(41,42)28-8-6-5-7-27(28)33(34,35)36)22(2)18-37(21)20-32(40)16-15-30(3)23(17-32)9-10-24-25-11-12-29(39)31(25,4)14-13-26(24)30/h5-8,21-26,40H,9-20H2,1-4H3/t21-,22+,23-,24+,25+,26+,30+,31-,32+/m1/s1

Standard InChI Key:  IYHGEKFCMCXIEF-XRZJBGKXSA-N

Molfile:  

     RDKit          2D

 47 52  0  0  0  0  0  0  0  0999 V2000
   14.0821  -16.5584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6776  -15.8527    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.2687  -16.5558    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5679  -12.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5679  -13.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2732  -13.9047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2732  -12.2703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9785  -12.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9750  -13.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6771  -13.9095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3871  -13.5062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6840  -12.2752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3867  -12.6915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4035  -11.0609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6893  -11.4607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1062  -11.4772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0973  -12.2910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8685  -12.5509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3541  -11.8977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8829  -11.2343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1438  -10.4599    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.1009  -10.6566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0926  -13.1081    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   19.3786  -11.8741    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   18.6770  -13.0916    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   17.9671  -14.3133    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   17.9712  -11.8658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5638  -14.3174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8541  -14.7224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8581  -13.0916    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.1625  -14.2822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4422  -14.6606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4073  -15.4774    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0990  -15.9144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8255  -15.5346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0656  -16.7309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1964  -13.4657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9931  -15.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0301  -14.6080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3442  -14.1723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6224  -14.5490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5907  -15.3659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2773  -15.7980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2467  -16.6147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9387  -17.0494    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.5242  -16.9965    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.2414  -17.4293    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  7  1  0
  5  6  1  0
  6  9  1  0
  8  7  1  0
  8  9  1  0
  8 12  1  0
  9 10  1  0
 10 11  1  0
 11 13  1  0
 12 13  1  0
 12 15  1  0
 13 17  1  0
 16 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
 20 21  2  0
 16 22  1  6
 17 23  1  6
 13 24  1  1
 12 25  1  6
  9 26  1  1
  8 27  1  1
  5 28  1  0
 28 29  1  0
  5 30  1  1
 29 31  1  0
 29 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  6
 31 37  1  1
 33  2  1  0
  2 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 38  1  0
 43 44  1  0
 44 45  1  0
 44 46  1  0
 44 47  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4076831

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 624.81

Molecular Weight (Monoisotopic): 624.3209

AlogP: 6.13

#Rotatable Bonds: 4

Polar Surface Area: 77.92

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: 2

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 2

CX Acidic pKa: ┄

CX Basic pKa: 7.37

CX LogP: 6.10

CX LogD: 5.82

Aromatic Rings: 1

Heavy Atoms: 43

QED Weighted: 0.44

Np Likeness Score: 0.54

References

1. Cortés-Benítez F, Roy J, Maltais R, Poirier D..  (2017)  Impact of androstane A- and D-ring inversion on 17β-hydroxysteroid dehydrogenase type 3 inhibitory activity, androgenic effect and metabolic stability.,  25  (7): [PMID:28254377] [10.1016/j.bmc.2017.02.008]

Source

Source(1):

• Scientific Literature